Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN5 SHORT NOTE 5M ★ High-yield

Describe cisplatin and the platinum compounds with their uses and toxicity.

Pharmacology · 2nd Professional — Para-Clinical

Mechanism and the Platinum Compounds

Cisplatin is a platinum coordination complex that forms intrastrand and interstrand DNA cross-links, chiefly between adjacent guanines. It behaves like an alkylating agent and is cell cycle non-specific.

DrugDistinctive featuresDose-limiting toxicity
CisplatinThe most potent; requires vigorous hydrationNephrotoxicity
CarboplatinMuch less nephrotoxic, ototoxic and emetogenic; dosed by renal function using the Calvert formula rather than by surface areaMyelosuppression, particularly thrombocytopenia
OxaliplatinActive in colorectal cancer, where the others are not; a component of FOLFOXPeripheral neuropathy, characteristically triggered and worsened by cold

Uses

  • Testicular cancer — cisplatin-based combination therapy (BEP) transformed a usually fatal disease into one cured in the great majority, and remains among the outstanding achievements of medical oncology
  • Ovarian cancer — carboplatin with paclitaxel
  • Lung cancer, both small cell and non-small cell
  • Head and neck cancer, often with radiotherapy as a radiosensitiser
  • Bladder, cervical, oesophageal and gastric cancer
  • Colorectal cancer — oxaliplatin specifically

Toxicity of Cisplatin

ToxicityFeaturesPrevention
Nephrotoxicity — dose-limitingProximal tubular damage, reduced glomerular filtration, and marked renal wasting of magnesium and potassium; may be cumulative and irreversibleVigorous pre- and post-hydration with saline, forced diuresis, magnesium supplementation, and avoiding other nephrotoxins
Severe vomitingAmong the most emetogenic drugs known; both acute and delayed5-HT3 antagonist + dexamethasone + NK1 antagonist, given prophylactically
OtotoxicityIrreversible high-frequency sensorineural hearing loss and tinnitus, from hair cell damage; particularly serious in childrenBaseline and serial audiometry; sodium thiosulphate is protective in children
Peripheral neuropathySensory, glove-and-stocking, cumulative; often incompletely reversibleDose reduction; no effective prophylaxis
Electrolyte disturbanceHypomagnesaemia (almost universal), hypokalaemia, hypocalcaemiaRoutine magnesium replacement
MyelosuppressionModerateMonitoring
OthersHypersensitivity; rarely optic neuritis and haemolytic-uraemic syndrome—

CLINICAL PEARL

Cisplatin is nephrotoxic and its major toxicities are all cumulative and largely irreversible — which changes how the drug is given. Hearing loss, neuropathy and renal damage do not recover meaningfully when the drug is stopped, so the emphasis falls entirely on prevention: hydration before the damage, audiometry before the deafness, and a decision to reduce or switch to carboplatin before the neuropathy is disabling.

Resistance

  • Increased DNA repair of platinum adducts — the principal mechanism, which is why tumours with defective repair (BRCA-mutated) are unusually platinum-sensitive
  • Inactivation by glutathione and metallothioneins, which bind the platinum
  • Reduced uptake through loss of the copper transporter CTR1
  • Failure of apoptosis, often through p53 mutation
  • "Platinum-sensitive" relapse — in ovarian cancer, relapse more than 6 months after treatment usually responds to platinum again, whereas earlier relapse does not; this distinction guides second-line treatment

Applied Aspects

  • Never give cisplatin without adequate hydration and a check of renal function and magnesium before each cycle
  • Check magnesium routinely and replace it; hypomagnesaemia is almost universal, causes tetany, arrhythmia and weakness, and prevents correction of potassium and calcium until it is treated
  • Arrange audiometry in children before and during treatment; hearing loss in a child has lifelong consequences for language and schooling, and switching to carboplatin may be preferable
  • Substitute carboplatin where renal function, hearing or neuropathy are a concern, accepting greater myelosuppression in exchange
  • Warn oxaliplatin patients to avoid cold drinks, cold air and touching cold objects in the days after infusion, since cold precipitates distressing pharyngolaryngeal dysaesthesia
  • Discuss fertility and sperm banking before treatment, particularly in testicular cancer where the patients are young and the cure rate is high — they will live with the consequences for decades

All questions in Blood, Haematinics & Anticancer Drugs

  1. Q1Define haematinics. Describe iron metabolism, iron preparations, vitamin B12 and folic acid with their uses. ★
  2. Q2Classify the haemostatic drugs. Describe vitamin K, tranexamic acid and the treatment of haemophilia. ★
  3. Q3Describe the general principles of cancer chemotherapy including the cell cycle, log kill hypothesis, combination therapy, resistance and toxicity. ★
  4. Q4Classify the cytotoxic anticancer drugs. Describe the alkylating agents, antimetabolites and natural products with their distinctive toxicities. ★
  5. Q5Describe the hormonal agents, targeted therapy and immunotherapy used in cancer. ★
  6. SN1Describe oral and parenteral iron therapy with the monitoring of response and the management of iron overload. ★
  7. SN2Describe vitamin B12 and folic acid with their deficiency states and treatment. ★
  8. SN3Describe the haematopoietic growth factors with their uses and adverse effects. ★
  9. SN4Describe methotrexate with its mechanism, uses, adverse effects and interactions. ★
  10. SN5Describe cisplatin and the platinum compounds with their uses and toxicity. ★
  11. SN6Describe the adverse effects of cancer chemotherapy and their prevention and management. ★
  12. SN7Classify the immunosuppressant drugs. Describe the calcineurin inhibitors and the complications of immunosuppression.

Every Pharmacology chapter →

Scroll to Top